Tumour Current Events | Tumour News | 11
|
| Page
11 of
14 |
263 Results |
|
|
|
Sort By:
Page Views | Date |
Testicular tumors may explain why some diseases are more common in children of older fathers
A rare form of testicular tumour has provided scientists with new insights into how genetic changes (mutations) arise in our children. view more (2009-10-26)
Removal of superficial tumours in oesophagus by endoscopy can avoid complete extirpation of this part of the digestive tract
The removal through endoscopy of tumours that affect only the superficial layers of the oesophagus can avoid complete extirpation of this part of the digestive tract. view more (2008-04-11)
Many oncologists unaware of cancer clot risk
Patients receiving cancer treatments are at greater risk of blood clots, yet more than a quarter of oncologists do not recognise their clotting effects and preventive measures are rarely used, finds a study in this week’s BMJ. view more (2003-09-10)
A new treatment for T-cell acute lymphoblastic leukaemia?
IL-7, a hormone-like protein involved in cell-cell interaction, has been associated with increased survival and expansion of T-cell acute lymphoblastic leukaemia (T-ALL). Now, in the latest issue of the Journal of Experimental Medicine, a team of scientists, not only confirms the essential role of this protein in the disease but also, for the... view more... (2004-09-09)
DEFINITIVE STUDY OF CANCER WAITING TIMES SUGGESTS MAJOR CHALLENGE FOR NHS
The paper, by Spurgeon, Barwell and Kerr at the University of Birmingham, will provide valuable baseline data which can be used to set targets for improvement in cancer services. The authors invited all English acute hospital trusts to submit data on new patients diagnosed with cancer during October 1997. They received data from 98 per cent of the... view more... (2000-03-13)
Molecular profiling can accurately predict survival in colon cancer patients
Researchers in The Netherlands have developed a method of accurately predicting which patients with colon cancer are most likely to have their disease recur after surgery and who would, therefore, be likely to benefit from additional chemotherapy. view more (2007-09-26)
Award winning researchers reveal potential new role for Glivec
Geneva, Switzerland: Imatinib - or Glivec as it also known - looks as if it may become an effective treatment for yet another type of cancer. view more (2004-09-26)
Future for radioembolisation in patients with advanced hepatocellular carcinoma
Copenhagen, Denmark, Friday 24 April: Radioembolisation with Yttrium-90 (Y-90) glass microspheres is a safe and effective treatment for patients with advanced HCC ± portal vein thrombosis, according to new research presented today at EASL 2009, the Annual Meeting of the European Association for the Study of the Liver in Copenhagen, Denmark. view more (2009-04-24)
One Signal Elicits Thousands of Answers
Cell signaling mechanisms often transmit information via protein modifications, most importantly the reversible attachment of phosphate, the so-called protein phosphorylation. view more (2006-11-13)
Prostate Cancer Survival Benefit From A Combination Of Androgen Suppression And External Irradiation
Disease-free survival from advanced prostate cancer could be almost doubled if hormone-suppression therapy is used during and after radiotherapy for a duration of 3 years, suggest authors of an international study in this week's issue of THE LANCET. Long-term survival after radiotherapy for people with advanced prostate cancer is poor. Michel... view more... (2002-07-05)
Unnecessary hysterectomy more likely for less affluent women
Unnecessary hysterectomy is less likely to be carried out on affluent women, shows research in the Journal of Epidemiology and Community Health. view more (2002-05-13)
Identification of highly radiosensitive patients may lead to side effect-free radiotherapy
An international group of scientists has taken the first step on the road to targeting radiotherapy dosage to individual patients by means of their genetic characteristics. view more (2009-09-24)
Key protein regulating inflammation may prove relevant to controlling sepsis
Scientists at Singapore's Institute of Molecular and Cell Biology (IMCB), under the Agency for Science, Technology and Research (A*STAR), have identified the protein, WIP1, as the molecular "brake" that curbs severe inflammation in the body. view more (2009-05-15)
Cancer Research director receives SCI accolade
9 July 2003, London, UK: Professor Sir David Lane, Director of the Cancer Research UK Transformation Research Group, will be awarded the Society of Chemical Industry (SCI) 2003 Society Medal today. The medal will be presented in recognition of his exceptional services to applied chemistry and the improvement of society at the 122nd Annual Meeting... view more... (2003-07-08)
Families of children with cancer support human tissue research, study finds
Families of children with cancer support research using tissue samples left over after operations, a new study has found. view more (2008-04-02)
Improved rectal cancer outcome with surgical teaching initiative
High dose radiotherapy before abdominal operations for rectal cancer has been shown to reduce the rate of recurrence of the disease by about half. In this week’s issue of THE Lancet, A Lehander Martling and colleagues from the Karolinska Hospital, Sweden, and Basingstoke, UK, investigated whether this rate could be decreased further by a... view more... (2000-07-05)
Helping the aged gut replace good bacteria may reduce cancer risk
Eating certain foods can increase the number of protective microbes in the gut. These bacteria help prevent food poisoning and can reduce levels of some toxic chemicals that may cause cancer, scientists heard today (Wednesday 10 April 2002) at the spring meeting of the Society for General Microbiology at the University of Warwick. "We have... view more... (2002-04-02)
Adding cetuximab to chemotherapy reduces advanced lung cancer death risk by 13 percent
Patients with advanced non-small cell lung cancer who are given cetuximab (Erbitux) in addition to chemotherapy are 13% less likely to die than those who receive chemotherapy alone, regardless of which chemotherapy drug cocktail is used, new research finds. They also experience slower disease progression and an increased chance of tumour shrinkage. view more (2009-09-22)
Cancer Research UK supports additional TroVax phase II trial in colorectal cancer
Oxford BioMedica announced today that Cancer Research UK (CRUK) has agreed to conduct and sponsor an open label Phase II trial with Oxford BioMedica's leading cancer immunotherapy product, TroVax®, in colorectal cancer patients who have liver metastases. The decision by CRUK follows extensive review of the successful Phase I/II data of TroVax... view more... (2003-08-28)
Fat transforms vitamin C from 'good cop' into 'bad cop'
Fat in the stomach may cause vitamin C to promote, rather than prevent, the formation of certain cancer causing chemicals, reveals research published ahead of print in the journal Gut. view more (2007-09-04)
|
|
| Page
11 of
14 |
263 Results |
|
|
|
Sort By:
Page Views | Date |
|
